206 related articles for article (PubMed ID: 26513708)
1. AP39, A Mitochondrially Targeted Hydrogen Sulfide Donor, Exerts Protective Effects in Renal Epithelial Cells Subjected to Oxidative Stress in Vitro and in Acute Renal Injury in Vivo.
Ahmad A; Olah G; Szczesny B; Wood ME; Whiteman M; Szabo C
Shock; 2016 Jan; 45(1):88-97. PubMed ID: 26513708
[TBL] [Abstract][Full Text] [Related]
2. AP39, a novel mitochondria-targeted hydrogen sulfide donor, stimulates cellular bioenergetics, exerts cytoprotective effects and protects against the loss of mitochondrial DNA integrity in oxidatively stressed endothelial cells in vitro.
Szczesny B; Módis K; Yanagi K; Coletta C; Le Trionnaire S; Perry A; Wood ME; Whiteman M; Szabo C
Nitric Oxide; 2014 Sep; 41():120-30. PubMed ID: 24755204
[TBL] [Abstract][Full Text] [Related]
3. Both the H
Ahmad A; Szabo C
Pharmacol Res; 2016 Nov; 113(Pt A):348-355. PubMed ID: 27639598
[TBL] [Abstract][Full Text] [Related]
4. AP39, a Mitochondria-Targeted Hydrogen Sulfide Donor, Supports Cellular Bioenergetics and Protects against Alzheimer's Disease by Preserving Mitochondrial Function in APP/PS1 Mice and Neurons.
Zhao FL; Fang F; Qiao PF; Yan N; Gao D; Yan Y
Oxid Med Cell Longev; 2016; 2016():8360738. PubMed ID: 27057285
[TBL] [Abstract][Full Text] [Related]
5. The Slow-Releasing and Mitochondria-Targeted Hydrogen Sulfide (H
Pomierny B; Krzyżanowska W; Jurczyk J; Skórkowska A; Strach B; Szafarz M; Przejczowska-Pomierny K; Torregrossa R; Whiteman M; Marcinkowska M; Pera J; Budziszewska B
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360581
[TBL] [Abstract][Full Text] [Related]
6. The novel mitochondria-targeted hydrogen sulfide (H
Gerő D; Torregrossa R; Perry A; Waters A; Le-Trionnaire S; Whatmore JL; Wood M; Whiteman M
Pharmacol Res; 2016 Nov; 113(Pt A):186-198. PubMed ID: 27565382
[TBL] [Abstract][Full Text] [Related]
7. H
Juriasingani S; Akbari M; Chan JY; Whiteman M; Sener A
Nitric Oxide; 2018 Dec; 81():57-66. PubMed ID: 30393129
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria-targeted hydrogen sulfide donor AP39 improves neurological outcomes after cardiac arrest in mice.
Ikeda K; Marutani E; Hirai S; Wood ME; Whiteman M; Ichinose F
Nitric Oxide; 2015 Sep; 49():90-6. PubMed ID: 25960429
[TBL] [Abstract][Full Text] [Related]
9. AP39 ameliorates high fat diet-induced liver injury in young rats via alleviation of oxidative stress and mitochondrial impairment.
Yu Y; Ye SM; Liu DY; Yang LQ
Exp Anim; 2021 Nov; 70(4):553-562. PubMed ID: 34305077
[TBL] [Abstract][Full Text] [Related]
10. Mitochondria-targeted hydrogen sulfide donors versus acute oxidative gastric mucosal injury.
Magierowska K; Korbut E; Wójcik-Grzybek D; Bakalarz D; Sliwowski Z; Cieszkowski J; Szetela M; Torregrossa R; Whiteman M; Magierowski M
J Control Release; 2022 Aug; 348():321-334. PubMed ID: 35654168
[TBL] [Abstract][Full Text] [Related]
11. Supplementing preservation solution with mitochondria-targeted H
Zhu C; Su Y; Juriasingani S; Zheng H; Veramkovich V; Jiang J; Sener A; Whiteman M; Lacefield J; Nagpal D; Alotaibi F; Liu K; Zheng X
Am J Transplant; 2019 Nov; 19(11):3139-3148. PubMed ID: 31338943
[TBL] [Abstract][Full Text] [Related]
12. AP39, a mitochondria-targeting hydrogen sulfide (H
Karwi QG; Bornbaum J; Boengler K; Torregrossa R; Whiteman M; Wood ME; Schulz R; Baxter GF
Br J Pharmacol; 2017 Feb; 174(4):287-301. PubMed ID: 27930802
[TBL] [Abstract][Full Text] [Related]
13. AP39, a novel mitochondria-targeted hydrogen sulfide donor ameliorates doxorubicin-induced cardiotoxicity by regulating the AMPK/UCP2 pathway.
Zhang B; Li Y; Liu N; Liu B
PLoS One; 2024; 19(4):e0300261. PubMed ID: 38568919
[TBL] [Abstract][Full Text] [Related]
14. The mitochondria-targeted hydrogen sulfide donor AP39 improves health and mitochondrial function in a C. elegans primary mitochondrial disease model.
Fox BC; Slade L; Torregrossa R; Pacitti D; Szabo C; Etheridge T; Whiteman M
J Inherit Metab Dis; 2021 Mar; 44(2):367-375. PubMed ID: 33325042
[TBL] [Abstract][Full Text] [Related]
15. AP39, a Modulator of Mitochondrial Bioenergetics, Reduces Antiangiogenic Response and Oxidative Stress in Hypoxia-Exposed Trophoblasts: Relevance for Preeclampsia Pathogenesis.
Covarrubias AE; Lecarpentier E; Lo A; Salahuddin S; Gray KJ; Karumanchi SA; Zsengellér ZK
Am J Pathol; 2019 Jan; 189(1):104-114. PubMed ID: 30315766
[TBL] [Abstract][Full Text] [Related]
16. Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat.
Chatterjee PK; Cuzzocrea S; Brown PA; Zacharowski K; Stewart KN; Mota-Filipe H; Thiemermann C
Kidney Int; 2000 Aug; 58(2):658-73. PubMed ID: 10916089
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotection by H2S Donors: Nitric Oxide-Dependent and ‑Independent Mechanisms.
Chatzianastasiou A; Bibli SI; Andreadou I; Efentakis P; Kaludercic N; Wood ME; Whiteman M; Di Lisa F; Daiber A; Manolopoulos VG; Szabó C; Papapetropoulos A
J Pharmacol Exp Ther; 2016 Sep; 358(3):431-40. PubMed ID: 27342567
[TBL] [Abstract][Full Text] [Related]
18. The Mitochondria-Targeted H2S-Donor AP39 in a Murine Model of Combined Hemorrhagic Shock and Blunt Chest Trauma.
Wepler M; Merz T; Wachter U; Vogt J; Calzia E; Scheuerle A; Möller P; Gröger M; Kress S; Fink M; Lukaschewski B; Rumm G; Stahl B; Georgieff M; Huber-Lang M; Torregrossa R; Whiteman M; McCook O; Radermacher P; Hartmann C
Shock; 2019 Aug; 52(2):230-239. PubMed ID: 29927788
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of Dopamine D3 Receptor Attenuates Renal Ischemia-Reperfusion Injury via Increased Linkage With Gα12.
Wang Z; Guan W; Han Y; Ren H; Tang X; Zhang H; Liu Y; Fu J; He D; Asico LD; Jose PA; Zhou L; Chen L; Zeng C
Transplantation; 2015 Nov; 99(11):2274-84. PubMed ID: 25989500
[TBL] [Abstract][Full Text] [Related]
20. Atorvastatin protects against contrast-induced acute kidney injury via upregulation of endogenous hydrogen sulfide.
Yan L; Jiaqiong L; Yue G; Xiaoyong L; Xuexian T; Ming L; Yinglan L; Xinxue L; Zena H
Ren Fail; 2020 Nov; 42(1):270-281. PubMed ID: 33685337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
